Cargando…

Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial

BACKGROUND: To compare the effect of bimatoprost and the fixed combination latanoprost-timolol (LTFC) on 24-hour systolic (SBP) and diastolic (DBP) blood pressure and on 24-hour ocular perfusion pressure (OPP). METHODS: 200 patients with glaucoma or ocular hypertension, controlled on the unfixed com...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossetti, Luca, Sacchi, Matteo, Karabatsas, Costas H, Topouzis, Fotis, Vetrugno, Michele, Centofanti, Marco, Boehm, Andreas, Vorwerk, Christian, Goldblum, David, Fogagnolo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320581/
https://www.ncbi.nlm.nih.gov/pubmed/25613811
http://dx.doi.org/10.1186/1471-2415-15-7
_version_ 1782356146668961792
author Rossetti, Luca
Sacchi, Matteo
Karabatsas, Costas H
Topouzis, Fotis
Vetrugno, Michele
Centofanti, Marco
Boehm, Andreas
Vorwerk, Christian
Goldblum, David
Fogagnolo, Paolo
author_facet Rossetti, Luca
Sacchi, Matteo
Karabatsas, Costas H
Topouzis, Fotis
Vetrugno, Michele
Centofanti, Marco
Boehm, Andreas
Vorwerk, Christian
Goldblum, David
Fogagnolo, Paolo
author_sort Rossetti, Luca
collection PubMed
description BACKGROUND: To compare the effect of bimatoprost and the fixed combination latanoprost-timolol (LTFC) on 24-hour systolic (SBP) and diastolic (DBP) blood pressure and on 24-hour ocular perfusion pressure (OPP). METHODS: 200 patients with glaucoma or ocular hypertension, controlled on the unfixed combination of latanoprost and timolol or eligible for dual therapy being not being fully controlled on monotherapy were enrolled in a randomized, double-masked, placebo-controlled, multicentre clinical trial. They were randomized to LTFC (8 a.m.) or bimatoprost (8 p.m.) and received 24-hour IOP curve at baseline, 6 and 12 weeks (supine and sitting position IOPs were recorded at 8 p.m., midnight, 5 a.m., 8a.m., noon and 4 p.m.). Holter 24-hour blood pressure curve was obtained between weeks 2 and 12. SBP, DBP, OPP were calculated and compared with ANOVA. Rates of diastolic OPP (DPP) ≤50, ≤40, ≤30 mmHg in the 2 groups were calculated and compared using Fisher’s test. RESULTS: Mean baseline SBP and DBP were 136.5 ± 18.3 vs 134.2 ± 20.1 mmHg (p = 0.1) and 79.1 ± 10.2 vs 78.2 ± 10.1 mmHg (p = 0.4) in the bimatoprost and LTFC groups respectively. Holter SBP was significantly higher for bimatoprost (135.1 mmHg vs 128.1 mmHg, p = 0.04), while no statistically significant difference in DBP was found. DPP was similar in the 2 groups, and proportions of patients with at least one value of the 24-hour curve ≤50, ≤40, ≤30 mmHg were 94%, 86%, 41% respectively. CONCLUSIONS: Bimatoprost and LTFC had similar DBPs and OPPs; SBP was significantly lower with LTFC. In this study, the percentage of “dippers” was considerably higher than the one described in previous studies on the role of perfusion pressure in glaucoma. TRIAL REGISTRATION: NCT02154217, May 21, 2014.
format Online
Article
Text
id pubmed-4320581
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43205812015-02-08 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial Rossetti, Luca Sacchi, Matteo Karabatsas, Costas H Topouzis, Fotis Vetrugno, Michele Centofanti, Marco Boehm, Andreas Vorwerk, Christian Goldblum, David Fogagnolo, Paolo BMC Ophthalmol Research Article BACKGROUND: To compare the effect of bimatoprost and the fixed combination latanoprost-timolol (LTFC) on 24-hour systolic (SBP) and diastolic (DBP) blood pressure and on 24-hour ocular perfusion pressure (OPP). METHODS: 200 patients with glaucoma or ocular hypertension, controlled on the unfixed combination of latanoprost and timolol or eligible for dual therapy being not being fully controlled on monotherapy were enrolled in a randomized, double-masked, placebo-controlled, multicentre clinical trial. They were randomized to LTFC (8 a.m.) or bimatoprost (8 p.m.) and received 24-hour IOP curve at baseline, 6 and 12 weeks (supine and sitting position IOPs were recorded at 8 p.m., midnight, 5 a.m., 8a.m., noon and 4 p.m.). Holter 24-hour blood pressure curve was obtained between weeks 2 and 12. SBP, DBP, OPP were calculated and compared with ANOVA. Rates of diastolic OPP (DPP) ≤50, ≤40, ≤30 mmHg in the 2 groups were calculated and compared using Fisher’s test. RESULTS: Mean baseline SBP and DBP were 136.5 ± 18.3 vs 134.2 ± 20.1 mmHg (p = 0.1) and 79.1 ± 10.2 vs 78.2 ± 10.1 mmHg (p = 0.4) in the bimatoprost and LTFC groups respectively. Holter SBP was significantly higher for bimatoprost (135.1 mmHg vs 128.1 mmHg, p = 0.04), while no statistically significant difference in DBP was found. DPP was similar in the 2 groups, and proportions of patients with at least one value of the 24-hour curve ≤50, ≤40, ≤30 mmHg were 94%, 86%, 41% respectively. CONCLUSIONS: Bimatoprost and LTFC had similar DBPs and OPPs; SBP was significantly lower with LTFC. In this study, the percentage of “dippers” was considerably higher than the one described in previous studies on the role of perfusion pressure in glaucoma. TRIAL REGISTRATION: NCT02154217, May 21, 2014. BioMed Central 2015-01-22 /pmc/articles/PMC4320581/ /pubmed/25613811 http://dx.doi.org/10.1186/1471-2415-15-7 Text en © Rossetti et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rossetti, Luca
Sacchi, Matteo
Karabatsas, Costas H
Topouzis, Fotis
Vetrugno, Michele
Centofanti, Marco
Boehm, Andreas
Vorwerk, Christian
Goldblum, David
Fogagnolo, Paolo
Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
title Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
title_full Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
title_fullStr Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
title_full_unstemmed Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
title_short Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
title_sort comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320581/
https://www.ncbi.nlm.nih.gov/pubmed/25613811
http://dx.doi.org/10.1186/1471-2415-15-7
work_keys_str_mv AT rossettiluca comparisonoftheeffectsofbimatoprostandafixedcombinationoflatanoprostandtimololon24hourbloodandocularperfusionpressurestheresultsofarandomizedtrial
AT sacchimatteo comparisonoftheeffectsofbimatoprostandafixedcombinationoflatanoprostandtimololon24hourbloodandocularperfusionpressurestheresultsofarandomizedtrial
AT karabatsascostash comparisonoftheeffectsofbimatoprostandafixedcombinationoflatanoprostandtimololon24hourbloodandocularperfusionpressurestheresultsofarandomizedtrial
AT topouzisfotis comparisonoftheeffectsofbimatoprostandafixedcombinationoflatanoprostandtimololon24hourbloodandocularperfusionpressurestheresultsofarandomizedtrial
AT vetrugnomichele comparisonoftheeffectsofbimatoprostandafixedcombinationoflatanoprostandtimololon24hourbloodandocularperfusionpressurestheresultsofarandomizedtrial
AT centofantimarco comparisonoftheeffectsofbimatoprostandafixedcombinationoflatanoprostandtimololon24hourbloodandocularperfusionpressurestheresultsofarandomizedtrial
AT boehmandreas comparisonoftheeffectsofbimatoprostandafixedcombinationoflatanoprostandtimololon24hourbloodandocularperfusionpressurestheresultsofarandomizedtrial
AT vorwerkchristian comparisonoftheeffectsofbimatoprostandafixedcombinationoflatanoprostandtimololon24hourbloodandocularperfusionpressurestheresultsofarandomizedtrial
AT goldblumdavid comparisonoftheeffectsofbimatoprostandafixedcombinationoflatanoprostandtimololon24hourbloodandocularperfusionpressurestheresultsofarandomizedtrial
AT fogagnolopaolo comparisonoftheeffectsofbimatoprostandafixedcombinationoflatanoprostandtimololon24hourbloodandocularperfusionpressurestheresultsofarandomizedtrial